Clinical Trials Browser

OTHER_GOV × Nivolumab × Lymphoid × Clear all

NCT03245021 2024-07-30

1stFLOR

Phase 1 Active not recruiting

Lymphoma, Follicular

NCT05385263 2022-05-26

Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion

Phase 2 Unknown

Lymphoma, B-Cell

NCT03569696 2019-04-23

NivoM

Phase 2 Unknown

Lymphoma, B-Cell